Last reviewed · How we verify

NCT06349109

Physical Activity in Children With Wolff-Parkinson-White Syndrome

Completed Last updated 29 January 2025
What this trial tests

trial testing Cardiopulmonary exercise test in Wolff-Parkinson-White Syndrome in 26 participants. Completed in 1 December 2024.

Timeline
1 March 2024
Primary endpoint
1 December 2024
1 December 2024

Quick facts

Lead sponsorKaramanoğlu Mehmetbey University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment26
Start date1 March 2024
Primary completion1 December 2024
Estimated completion1 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karamanoğlu Mehmetbey University

Who can join

Adults 7 to 18, any sex, with Wolff-Parkinson-White Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the level of physical activity and its determinants in children with WPW.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Physical activity level and influencing factors in pediatric Wolff-Parkinson-White syndrome patients: A case-control study.
    Tekerlek H, Özcan EB, Çetin T, Sağlam M, et al · · 2025 · PMID 40634817 · DOI 10.1007/s00431-025-06290-7

Verify or expand the search:

Other trials of Cardiopulmonary exercise test

Trials testing the same drug.

Other Karamanoğlu Mehmetbey University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing